Business

Canandaigua National Corp Buys Shares of 618 Waters Co. (NYSE:WAT)

Canandaigua National Corp Buys Shares of 618 Waters Co. (NYSE:WAT) #Canandaigua #National #Corp #Buys #Shares #Waters #NYSEWAT Welcome to Americanah Blog, here is the new story we have for you today:

You Can Click Here To View Restricted Videos/Images in this Article

Canandaigua National Corp purchased a new stake in shares of Waters Co. (NYSE:WATGet Rating) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 618 shares of the medical instruments supplier’s stock, valued at approximately $205,000.

A number of other institutional investors have also recently made changes to their positions in the company. Ensign Peak Advisors Inc increased its holdings in Waters by 157.7% in the 4th quarter. Ensign Peak Advisors Inc now owns 22,022 shares of the medical instruments supplier’s stock valued at $8,206,000 after acquiring an additional 13,475 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Waters by 2.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 312,564 shares of the medical instruments supplier’s stock valued at $116,461,000 after buying an additional 8,692 shares during the period. Geode Capital Management LLC raised its holdings in shares of Waters by 1.9% in the 4th quarter. Geode Capital Management LLC now owns 1,183,053 shares of the medical instruments supplier’s stock valued at $439,993,000 after purchasing an additional 21,757 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Waters by 15.5% in the 4th quarter. Invesco Ltd. now owns 969,123 shares of the medical instruments supplier’s stock valued at $361,093,000 after purchasing an additional 129,837 shares in the last quarter. Finally, Schroder Investment Management Group raised its stake in shares of Waters by 124.6% during the 4th quarter. Schroder Investment Management Group now owns 229,736 shares of the medical instruments supplier’s stock worth $85,599,000 after acquiring an additional 127,458 shares in the last quarter. Hedge funds and other institutional investors own 88.80% of the company’s stock.

Waters Stock Performance

Waters stock opened at $281.98 on Wednesday. The stock has a market cap of $16.88 billion, a P/E ratio of 24.61, a price-to-earnings-growth ratio of 3.15 and a beta of 0.87. The company has a current ratio of 2.10, a quick ratio of 1.55 and a debt-to-equity ratio of 3.66. The stock has a 50 day moving average of $322.71 and a 200-day moving average of $321.48. Waters Co. has a 52 week low of $279.15 and a 52 week high of $405.06.

Waters (NYSE:WATGet Rating) last posted its quarterly earnings results on Tuesday, August 2nd. The medical instruments supplier reported $2.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.12. The business had revenue of $714.30 million for the quarter, compared to analyst estimates of $706.77 million. Waters had a return on equity of 203.31% and a net margin of 24.21%. The business’s revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the company posted $2.60 EPS. On average, analysts expect that Waters Co. will post 12 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently commented on WAT. UBS Group upped their price objective on shares of Waters from $349.00 to $375.00 and gave the company a “neutral” rating in a report on Thursday, August 4th. Credit Suisse Group started coverage on shares of Waters in a research note on Wednesday, August 24th. They set a “neutral” rating and a $345.00 target price for the company. Robert W. Baird raised their target price on shares of Waters from $340.00 to $348.00 in a report on Wednesday, August 3rd. Barclays cut their price objective on shares of Waters from $375.00 to $345.00 and set an “overweight” rating on the stock in a report on Monday, September 12th. Finally, Cowen lifted their target price on shares of Waters to $378.00 in a report on Tuesday, August 9th. Five investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Waters has an average rating of “Hold” and a consensus price target of $348.25.

About Waters

(Get Rating)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Waters and related companies with MarketBeat.com’s FREE daily email newsletter.

Click Here To Continue Reading from Source

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button